Posted by Michael Wonder on 29 Sep 2016

FDA eyes new diabetes outcome measures

Nature Reviews Drug Discovery

29 September 2016 - A recent FDA workshop brought new diabetes outcome measures to the table, focusing on patient-oriented outcome measures.

Read Nature Reviews Drug Discovery article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Outcome , Medicine , Pharmaceutical industry , Drug development , Type 2 diabetes mellitus , Guidelines